140 related articles for article (PubMed ID: 20662311)
1. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans.
Anraku M; Arahira M; Mady FM; Khaled KA; Yamasaki K; Seo H; Imai T; Otagiri M
Pharmazie; 2010 Jul; 65(7):461-6. PubMed ID: 20662311
[TBL] [Abstract][Full Text] [Related]
2. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670
[TBL] [Abstract][Full Text] [Related]
3. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin.
Uchiyama H; Tozuka Y; Imono M; Takeuchi H
Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634
[TBL] [Abstract][Full Text] [Related]
4. One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier.
Mizoe T; Beppu S; Ozeki T; Okada H
J Control Release; 2007 Jul; 120(3):205-10. PubMed ID: 17582644
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Chong S
Arch Pharm Res; 2010 Jan; 33(1):3-4. PubMed ID: 20191338
[No Abstract] [Full Text] [Related]
6. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
[TBL] [Abstract][Full Text] [Related]
7. Transglycosylated stevia and hesperidin as pharmaceutical excipients: dramatic improvement in drug dissolution and bioavailability.
Uchiyama H; Tozuka Y; Imono M; Takeuchi H
Eur J Pharm Biopharm; 2010 Oct; 76(2):238-44. PubMed ID: 20637868
[TBL] [Abstract][Full Text] [Related]
8. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
9. Dissolution profiles of flurbiprofen in phospholipid solid dispersions.
Habib MJ; Phan MT; Owusu-Ababio G
Drug Dev Ind Pharm; 1998 Nov; 24(11):1077-82. PubMed ID: 9876563
[TBL] [Abstract][Full Text] [Related]
10. Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs.
Imai T; Nishiyama T; Shameem M; Otagiri M
Pharm Dev Technol; 1998 May; 3(2):225-32. PubMed ID: 9653760
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
[TBL] [Abstract][Full Text] [Related]
13. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement.
Berber MR; Minagawa K; Katoh M; Mori T; Tanaka M
Eur J Pharm Sci; 2008 Nov; 35(4):354-60. PubMed ID: 18789388
[TBL] [Abstract][Full Text] [Related]
14. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.
Rajendrakumar K; Madhusudan S; Pralhad T
Eur J Pharm Biopharm; 2005 May; 60(1):39-46. PubMed ID: 15848054
[TBL] [Abstract][Full Text] [Related]
17. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
18. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm.
Imberti R; De Gregori S; Lisi L; Navarra P
Pharmacology; 2014; 94(3-4):143-7. PubMed ID: 25277061
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
Zhao X; Li W; Luo Q; Zhang X
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
[TBL] [Abstract][Full Text] [Related]
20. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug.
Aiedeh KM; Khatib HA; Taha MO; Al-Zoubi N
Pharmazie; 2006 Apr; 61(4):306-11. PubMed ID: 16649543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
